Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Low Volatility Dividend Stocks to Invest in. On February 20, Barclays began coverage of Bristol-Myers Squibb Company (NYSE:BMY) ...

FDA-approved Andexxa reversed Xarelto and Eliquis bleeding but was linked to higher rates of blood clots and death, ...

CRISPR Therapeutics stays a Hold as CASGEVY launch lags; watch cash burn, revenue delays, and CTX310/CTX611 catalysts for 2026. Click here to read now.

Clive Hyman was 64 years old and had only been married four years. Despite being relatively fit and healthy for his age, he died suddenly, days after a seemingly minor trip on some stairs. "Clive ...

For full-year 2025, revenues from the legacy portfolio fell 15% to $21.8 billion, representing 45% of Bristol Myers’ total revenues of $48.2 billion. Management expects this segment to decline a ...

It said it expects Eliquis sales to fall $1.5 billion to $2 billion in 2027 after the blood clot ​preventer loses patent protection in Europe toward the end of the year. Bristol Myers said it expects ...

SAN DIEGO -- Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, regardless of their obesity status, a database study involving ...

FRANKFURT, Feb 5 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Thursday its experimental blood thinner cut the risk of stroke recurrence by 26% in a late-stage trial, in a fresh boost for CEO ...

By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying that price cuts to its blood thinner Eliquis will help drive up revenue, ...

Larry Bordeaux, 65, has been on blood thinners since 2010, after he started developing deadly clots following an operation. He credits the drugs with saving his life. If he stops taking them for ...